share_log
Benzinga ·  May 24, 2024 16:48
Vanda Pharmaceuticals Rejects Revised Unsolicited Acquisition Proposal From Future Pak, Concluding It Undervalues The Company; Board Unanimously Decides Proposal Is Not In The Best Interests Of Shareholders
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment